ArticleJACC. Advances2026

The Role of Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Cardiovascular-Kidney-Metabolic Syndrome.

Sonal Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.